Intensive therapies for mantle cell lymphoma: time for a disease-specific approach?

Authors :: Smith SD
Sweetenham JW
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2010 Mar; Vol. 51 (3), pp. 357-9.
Publication Year :: 2010

Subjects :: Antibodies, Monoclonal administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antigens, Neoplasm biosynthesis
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Cell Line, Tumor
Clinical Trials as Topic
Follow-Up Studies
Humans
Ki-67 Antigen biosynthesis
Middle Aged
Rituximab
Time Factors
Translocation, Genetic
Treatment Outcome
Lymphoma, Mantle-Cell therapy
Medical Oncology methods

Full Text Access

Tools